Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Roche highly encouraged by Tecentriq results in breast cancer

      Roche highly encouraged by Tecentriq results in breast cancer

      Ruby Khatun Khatun4 July 2018 9:45 AM IST
      ZURICH: Swiss drugmaker Roche said that a trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of...
      Sanofi beefs up diabetes pipeline to retrieve success

      Sanofi beefs up diabetes pipeline to retrieve success

      Ruby Khatun Khatun4 July 2018 9:30 AM IST
      PARIS: Sanofi sees a more diversified pipeline driving a return to growth at its diabetes unit in the coming years and will consider acquisitions and...
      Delhi needs to follow Andhra policy on Auto Disable syringes

      Delhi needs to follow Andhra policy on Auto Disable syringes

      Ruby Khatun Khatun3 July 2018 4:25 PM IST
      Andhra Pradesh is the first state in India to have come out with a policy around Auto-Disable (AD) syringes.In the national capital, many of the...
      Natco launches Hepatitis C drug in India at Rs 17,500

      Natco launches Hepatitis C drug in India at Rs 17,500

      Ruby Khatun Khatun3 July 2018 10:30 AM IST
      Hyderabad: Natco Pharma said it has launched a fixed-dose combination of Sofosbuvir-Daclatasvir tablets for the treatment of Hepatitis C under the...
      Boiron launches pre-medicated homeopathic medicines in India

      Boiron launches pre-medicated homeopathic medicines in India

      Ruby Khatun Khatun3 July 2018 10:15 AM IST
      New Delhi: Boiron India, subsidiary of Boiron France, has launched pre-medicated standardized homeopathic medicines for the first time in the...
      Ferring launches work on facility in Hyderabads Genome Valley

      Ferring launches work on facility in Hyderabad's Genome Valley

      Ruby Khatun Khatun3 July 2018 10:00 AM IST
      Hyderabad: Ferring Pharmaceuticals, a pharma major from Europe, laid the foundation stone for their state-of-the-art R&D laboratory and...
      Novartis hands investors Alcon spin-off, 5 billion dollar share buyback

      Novartis hands investors Alcon spin-off, 5 billion dollar share buyback

      Ruby Khatun Khatun3 July 2018 9:45 AM IST
      ZURICH: Novartis plans to spin off its Alcon eye care business to shareholders and buy back up to $5 billion in stock as Chief Executive Vas...
      AstraZeneca wins speedy approvals for cancer drugs in Japan

      AstraZeneca wins speedy approvals for cancer drugs in Japan

      Ruby Khatun Khatun3 July 2018 9:30 AM IST
      LONDON: AstraZeneca has won rapid regulatory approval for new uses of two of its important cancer drugs in Japan, less than six months after the first...
      Oxytocin ban: CDSCO raids in Bihar on Illegal Manufacturing, import

      Oxytocin ban: CDSCO raids in Bihar on Illegal Manufacturing, import

      Ruby Khatun Khatun2 July 2018 3:01 PM IST
      New Delhi: The Central Drug Standards Control Organisation (CDSCO) conducted raids at various locations in Bihar in a crackdown on illegal...
      Dr Reddys recalls 2.36 lakh bottles of cholesterol lowering tablets from US

      Dr Reddy's recalls 2.36 lakh bottles of cholesterol lowering tablets from US

      Ruby Khatun Khatun2 July 2018 11:37 AM IST
      New Delhi: Dr Reddy's Laboratories is recalling from the US over 2.36 lakh bottles of Atorvastatin Calcium tablets used for lowering cholesterol, as...
      Zydus Cadila gets USFDA nod for blood pressure drug

      Zydus Cadila gets USFDA nod for blood pressure drug

      Ruby Khatun Khatun2 July 2018 10:30 AM IST
      New Delhi: Zydus Cadila said it has received USFDA approval to market Triamterene and Hydrochlorothiazide tablets, indicated to treat high blood...
      Rival Novartis, Gilead CAR-T therapies win European panel recommendation

      Rival Novartis, Gilead CAR-T therapies win European panel recommendation

      Ruby Khatun Khatun2 July 2018 10:00 AM IST
      ZURICH: Rival cancer cell therapies from Swiss drugmaker Novartis and U.S.-based Gilead Sciences won a key recommendation from a European Medicines...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok